Author:
Koshman Yevgeniya E.,Winters Brett R.,Ryans Julie,Authier Simon,Pugsley Michael K.
Publisher
Springer International Publishing
Reference48 articles.
1. Authier S, Pugsley MK, Troncy E, Curtis MJ (2013) Cardiovascular biomarkers as examples of success and failure in predicting safety in humans. In: Williams JA, Lalonde R, Koup JR, Christ DD (eds) Predictive approaches in drug discovery & development: biomarkers and in vitro/in vivo correlations. Wiley Interscience, Hoboken
2. van Berlo D, Woutersen M, Muller A, Pronk M, Vriend J, Hakkert B (2022) 10% body weight (gain) change as criterion for the maximum tolerated dose: a critical analysis. Regul Toxicol Pharmacol 134:105235. https://doi.org/10.1016/j.yrtph.2022.105235
3. Berridge BR, Pettit S, Walker DB, Jaffe AS et al (2009) A translational approach to detecting drug-induced cardiac injury with cardiac troponins: consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute. Am Heart J 158(1):21–29
4. Buttarello M (2016) Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how? Int J Lab Hematol 38(Suppl 1):123–132. https://doi.org/10.1111/ijlh.12500
5. Chui RW, Fosdick A, Conner R, Jiang J, Bruenner BA, Vargas HM (2009) Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants. J Pharmacol Toxicol Methods 60(1):58–68